A new study published in Annals of Allergy, Asthma & Immunology found patients with small airways dysfunction experienced statistically significant improvements in outcomes with tezepelumab. Kartik Shenoy, MD, Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University, provided commentary on the findings to Healio Pulmonology.